Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1985]

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's...

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen...

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma ( Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Prof John Gribben - Bart’s and )

iwNHL 10: Advances in the treatment of lymphoma

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Dr Myron...

iwNHL 10: Advances in the treatment of lymphoma ( Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal )

Cancer prevention and epidemiology in Russia

Dr David Zardize – Russian National Cancer Research Centre, Moscow, Russia

Cancer prevention and epidemiology in Russia ( Dr David Zardize – Russian National Cancer Research Centre, Moscow, Russia )

Potential for micro-RNA based cancer treatments

Prof Carlo Croce – Ohio State University, Columbus, USA

Potential for micro-RNA based cancer treatments ( Prof Carlo Croce – Ohio State University, Columbus, USA )

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain

Epigenetics of cancer and changes in DNA modification in tumours ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain )

Strategies to improve the tolerability of treatment in patients with multiple...

Prof Michel Delforge - Catholic University, Leuven, Belgium

Strategies to improve the tolerability of treatment in patients with multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter...

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands, )

Best treatment for chronic lymphocytic leukaemia with 17p deletion

Prof Michael Keating - MD Anderson Cancer Center, Houston, USA

Best treatment for chronic lymphocytic leukaemia with 17p deletion ( Prof Michael Keating - MD Anderson Cancer Center, Houston, USA )

The involvement of rare cancer patients in clinical research

Jan Geissler - Co-founder of CML Advocates Network

The involvement of rare cancer patients in clinical research ( Jan Geissler - Co-founder of CML Advocates Network )

New drugs on the CML horizon; choosing the correct therapies

Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio...

New drugs on the CML horizon; choosing the correct therapies ( Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - University of Turin, Italy, Dr Delphine Rea - Saint Louis Hospital, France )

The evolving landscape in the management of CML

Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio...

The evolving landscape in the management of CML ( Jan Geissler - Co-founder of CML Advocates Network, Prof Giuseppe Saglio - University of Turin, Italy, Dr Delphine Rea - Saint Louis Hospital, France )

Maintenance therapy in multiple myeloma; the way forward

Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo...

Maintenance therapy in multiple myeloma; the way forward ( Prof Gareth Morgan - The Royal Marsden Hospital, London, Prof Antonio Palumbo - University Hospital of Torino, Italy, Dr Paul Richardson - Dana-Farber Cancer Institute, USA )

More from ecancer